Featured

ICYMI: Biopharmaceutical Companies Aren’t Free-Riding on Government Research

Writing for the Boston Globe, Dr. Michael Rosenblatt, chief medical officer of the venture firm …

Read More
Filter posts

As Mosquito Fears Rise, EPA Considers Oxitec 2nd Generation Trial

Most people consider mosquitoes to be a summertime pest – the unwelcome guest at the …

This Fashion Month, Learn About the Benefits of GMO Cotton

Even as this year’s New York Fashion Week comes to a close, it’s important to …

ICYMI: Biopharmaceutical Companies Aren’t Free-Riding on Government Research

Writing for the Boston Globe, Dr. Michael Rosenblatt, chief medical officer of the venture firm …

From Treatments to Cures – BIO Partnering Sets the Stage

The fight against HIV has moved off the front pages. Advancements in antiretroviral drugs are …

More Meetings, More Results with BIO One-on-One Partnering

Innovate Biopharmaceuticals has had more meetings through BIO’s One-on-One Partnering™ than they can count. In …

Nominate Your Company to be the Buzz of BIO!

Is your company seeking a next round of financing or hoping to make the valuable …